These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24101108)

  • 1. Effect of endothelin inhibition on lung fibroblasts on patients with systemic sclerosis.
    Corrado A; Neve A; Costantino E; Palladino GP; Foschino Barbaro MP; Cantatore FP
    Minerva Med; 2013 Oct; 104(5):505-17. PubMed ID: 24101108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients.
    Soldano S; Montagna P; Brizzolara R; Ferrone C; Parodio A; Sulli A; Seriolo B; Villaggio B; Cutolo M
    Reumatismo; 2012 Dec; 64(5):326-34. PubMed ID: 23256109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.
    Corallo C; Cutolo M; Kahaleh B; Pecetti G; Montella A; Chirico C; Soldano S; Nuti R; Giordano N
    Arthritis Res Ther; 2016 Oct; 18(1):228. PubMed ID: 27716320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis.
    Jelaska A; Korn JH
    Arthritis Rheum; 2000 Oct; 43(10):2230-9. PubMed ID: 11037882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts.
    Cutolo M; Ruaro B; Montagna P; Brizzolara R; Stratta E; Trombetta AC; Scabini S; Tavilla PP; Parodi A; Corallo C; Giordano N; Paolino S; Pizzorni C; Sulli A; Smith V; Soldano S
    Arthritis Res Ther; 2018 May; 20(1):77. PubMed ID: 29720235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts.
    Cutolo M; Montagna P; Brizzolara R; Smith V; Alessandri E; Villaggio B; Sulli A; Tavilla PP; Pizzorni C; Soldano S
    J Rheumatol; 2015 Mar; 42(3):456-63. PubMed ID: 25593238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis.
    Dees C; Tomcik M; Zerr P; Akhmetshina A; Horn A; Palumbo K; Beyer C; Zwerina J; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2011 Jul; 70(7):1304-10. PubMed ID: 21450749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate.
    Dooley A; Shi-Wen X; Aden N; Tranah T; Desai N; Denton CP; Abraham DJ; Bruckdorfer R
    Rheumatology (Oxford); 2010 Nov; 49(11):2024-36. PubMed ID: 20627968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of PDGF-A/PDGFR-α in proliferation and transdifferentiation of fibroblasts from skin lesions of patients with systemic sclerosis].
    Liu T; Zhang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):496-501. PubMed ID: 22543129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation.
    Zhu L; Song Y; Li M
    J Dermatol Sci; 2015 Jan; 77(1):63-70. PubMed ID: 25465161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts.
    Karimizadeh E; Motamed N; Mahmoudi M; Jafarinejad-Farsangi S; Jamshidi A; Faridani H; Gharibdoost F
    Arch Dermatol Res; 2015 Mar; 307(2):135-42. PubMed ID: 25527259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation.
    Carulli MT; Ong VH; Ponticos M; Shiwen X; Abraham DJ; Black CM; Denton CP
    Arthritis Rheum; 2005 Dec; 52(12):3772-82. PubMed ID: 16320328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of N-acetyl-seryl-aspartyl-lysyl-proline on differentiation from pulmonary fibroblast to myofibroblast mediated by Rho-associated coiled-coil forming protein kinase pathway].
    Yuan Y; Yang F; Xu H; Yu WY; Sun Y; Deng HJ; Ma WD; Wei ZQ; Wang RM
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Sep; 31(9):654-60. PubMed ID: 24064119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous response of nasal and lung fibroblasts to transforming growth factor-beta 1.
    Nonaka M; Pawankar R; Fukumoto A; Yagi T
    Clin Exp Allergy; 2008 May; 38(5):812-21. PubMed ID: 18355371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
    Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma-Associated Lung Fibrosis.
    Bogatkevich GS; Atanelishvili I; Bogatkevich AM; Silver RM
    Arthritis Rheumatol; 2023 Mar; 75(3):438-448. PubMed ID: 36103378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts.
    Ichiki Y; Smith EA; LeRoy EC; Trojanowska M
    J Rheumatol; 1997 Jan; 24(1):90-5. PubMed ID: 9002017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of salvianolic acid B on TGF-β1-induced proliferation and differentiation in lung fibroblasts.
    Zhang M; Cao SR; Zhang R; Jin JL; Zhu YF
    Exp Lung Res; 2014 Apr; 40(4):172-85. PubMed ID: 24669910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From microvasculature to fibroblasts: Contribution of anti-endothelial cell antibodies in systemic sclerosis.
    Corallo C; Franci B; Lucani B; Montella A; Chirico C; Gonnelli S; Nuti R; Giordano N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):93-103. PubMed ID: 25816411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased alveolar concentration of nitric oxide is related to serum-induced lung fibroblast proliferation in patients with systemic sclerosis.
    Hua-Huy T; Tiev KP; Chéreau C; Duong-Quy S; Cabane J; Dinh-Xuan AT
    J Rheumatol; 2010 Aug; 37(8):1680-7. PubMed ID: 20595271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.